Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Radim Nemecek"'
Autor:
Judit Kocsis, Lucjan Wyrwicz, Wojciech Rogowski, Ron N. Apte, Aimery de Gramont, Thierry André, Prasant Mohanty, Krzysztof Lesniewski-Kmak, Tomasz Sarosiek, Radim Nemecek, Mark P Saunders, Tamas Hickish, Lubos Petruzelka, John Simard, Michael Stecher
Publikováno v:
The Lancet Oncology. 18:192-201
Summary Background MABp1, an antibody that targets interleukin 1α, has been associated with antitumour activity and relief of debilitating symptoms in patients with advanced colorectal cancer. We sought to establish the effect of MABp1 with a new pr
Autor:
Michal Eid, Jakub Foukal, Dana Sochorová, Štěpán Tuček, Karel Starý, Zdeněk Kala, Jiří Mayer, Radim Němeček, Jan Trna, Lumír Kunovský
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 13942-13957 (2023)
Abstract Pheochromocytomas (PCCs) are rare neuroendocrine tumors derived from the chromaffin cells of the adrenal medulla. When these tumors have an extra‐adrenal location, they are called paragangliomas (PGLs) and arise from sympathetic and parasy
Externí odkaz:
https://doaj.org/article/4939464a45db4af1862b544775718fa4
Autor:
Manuela Ferracin, Jitka Mlčochová, Stanislav John, Barbara Zagatti, Igor Kiss, Petra Faltejskova-Vychytilova, Massimo Negrini, Ondrej Slaby, Marek Svoboda, Radim Nemecek, Rostislav Vyzula, Lenka Radová
Publikováno v:
Oncotarget
// Jitka Mlcochova 1 , Petra Faltejskova-Vychytilova 1, 2 , Manuela Ferracin 3 , Barbara Zagatti 3 , Lenka Radova 1 , Marek Svoboda 2 , Radim Nemecek 2 , Stanislav John 4 , Igor Kiss 2 , Rostislav Vyzula 2 , Massimo Negrini 3 , Ondrej Slaby 1, 2 1 Ce
Publikováno v:
Journal of Cancer Research and Clinical Oncology
MicroRNAs (miRNAs) are short, 18-25-nucleotide long, non-coding single-stranded RNAs, which are capable to regulate gene expression on post-transcriptional level through binding to their target protein-encoding mRNAs. miRNAs regulate individual compo
Autor:
Ondrej Slaby, Tomas Kazda, Lenka Radová, Radim Nemecek, Jitka Berkovcová, Marek Svoboda, Jitka Mlčochová, Petra Vychytilova-Faltejskova
Publikováno v:
OncoTargets and therapy
Radim Nemecek,1 Jitka Berkovcova,2 Lenka Radova,3 Tomas Kazda,4 Jitka Mlcochova,3 Petra Vychytilova-Faltejskova,1,3 Ondrej Slaby,1,3 Marek Svoboda1 1Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Masaryk University, Brno,
Autor:
Prasant Mohanty, Radim Nemecek, Razelle Kurzrock, Lucjan Wyrwicz, Tomasz Sarosiek, Mike Stecher, Tamas Hickish, John Simard, Judit Kocsis, Thierry André, Qian Wu, Charles A. Dinarello
Publikováno v:
Annals of Oncology. 28:iii98-iii99
Autor:
Thierry André, Lucjan Wyrwicz, Prasant Mohanty, Tamas Hickish, John Simard, Tomasz Sarosiek, George A. Fisher, Radim Nemecek, Wojciech Rogowski, Mark P Saunders, Krzysztof Leśniewski-Kmak, Michael Stecher
Publikováno v:
Journal of Clinical Oncology. 35:3530-3530
3530 Background: Refractory metastatic colorectal cancer (mCRC) patients derive minimal benefit from further exposure to toxic agents. MABp1 is an anti-interleukin 1 alpha antibody that is shown to prolong survival (NCT01767857) and improves outcomes
Autor:
Mark P Saunders, Tamas Hickish, Judit Kocsis, Lucjan Wyrwicz, Tomasz Sarosiek, Radim Nemecek, A. de Gramont, T. Andre, Michael Stecher
Publikováno v:
Annals of Oncology. 27:ii128
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 25(5)
Autor:
Petr Burkoň, Jan Trna, Marek Slávik, Radim Němeček, Tomáš Kazda, Petr Pospíšil, Milan Dastych, Michal Eid, Ivo Novotný, Tomáš Procházka, Miroslav Vrzal
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2480 (2022)
Pancreatic cancer is the third leading cause of cancer death in the developed world and is predicted to become the second by 2030. A cure may be achieved only with surgical resection of an early diagnosed disease. Surgery for more advanced disease is
Externí odkaz:
https://doaj.org/article/2594ecae83bc4b18be4bc18adf821f00